drugset / Trial / NCT02605382
Efficacy of 0.12% Chlorhexidine Gluconate for Peri-implant Mucositis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to analyze the efficacy of 0.12% chlorhexidine gluconate as a chemical adjuvant for the treatment of peri-implant mucositis, in a non-surgical treatment protocol with a six-month follow-up.
Timeline
- Start
- 2012-10
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Chlorhexidine gluconate | Other / unclassified | 0.12 % | Oral |
| Subject | Chlorhexidine gluconate | Other / unclassified | 15 ml | Oral |